Astal Laboratories MD, chairman, board of directors and AGM
BSE: 512600Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹67.85.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹279 Cr2,455th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 14 Aug 2026
- 28.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 0.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 4.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.04
- Volume, BSEVolume. Shares traded on the last trading day.
- 13,208
Astal Laboratories board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Company Secretary and Compliance OfficerMahendra Kumar
7 directors4 independent1 executive2 non-executive
- SUDHEER KARNA KANKANALAExecutive · joined Sep 2022 · 1 listed board
- RAVIKANTI SHAILAJANon-executive · joined Sep 2022 · 1 listed board · 2 committee seats
- MAGGIDI VENKATESHNon-executive · joined Jun 2023 · 1 listed board
- HEMACHAKRAPANI BANGARAIAHGARIIndependent · joined Sep 2022 · 45 months as independent · 1 listed board · 1 as independent · 2 committee seats
- RADHAKISHORE PANDRANGIIndependent · joined Aug 2023 · 34 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
- BIRENDRAKUMAR SAHOOIndependent · joined May 2024 · 25 months as independent · 1 listed board · 1 as independent
- JULIUS PAUL REINHARD PASCHKEIndependent · joined Dec 2024 · 18 months as independent · 1 listed board · 1 as independent
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 29 Jun 20267 of 7 present4 independent · 29 days in between
- 30 May 20266 of 7 present3 independent · 4 days in between
- 25 May 20266 of 7 present3 independent · 12 days in between
- 12 May 20266 of 7 present3 independent · 86 days in between
2 earlier meetings
- 14 Feb 20267 of 7 present4 independent · 30 days in between
- 14 Jan 20266 of 7 present3 independent
Audit Committee
Chair RADHAKISHORE PANDRANGI
HEMACHAKRAPANI BANGARAIAHGARI, RAVIKANTI SHAILAJA
- 30 May 20263 of 3 present2 independent · 104 days in between
- 14 Feb 20263 of 3 present2 independent
Nomination and remuneration committee
Chair RADHAKISHORE PANDRANGI
HEMACHAKRAPANI BANGARAIAHGARI, RAVIKANTI SHAILAJA
- 25 May 20263 of 3 present2 independent · 99 days in between
- 14 Feb 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair RADHAKISHORE PANDRANGI
HEMACHAKRAPANI BANGARAIAHGARI, RAVIKANTI SHAILAJA
- 30 May 20263 of 3 present2 independent · 104 days in between
- 14 Feb 20263 of 3 present2 independent
Corporate Social Responsibility Committee
Chair SUDHEER KARNA KANKANALA
RAVIKANTI SHAILAJA, BIRENDRAKUMAR SAHOO
- 14 Feb 20263 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- M/s. Sathuluri & Co.Peer-review certificate valid to Oct 2027
1 earlier auditor
- Sathuluri & Co.Named in filings from Mar 2025 to Jun 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Astal Laboratories AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Astal Laboratories share news and announcements
Annual general meeting, 29 Sep 2026
3,436 shareholders on the register on 22 Sep 2026; present: 1 promoter and 30 others; votes counted by MAHENDRA PRAKASH KHANDELWAL / MAHENDRA KHANDELWAL & CO..The company's voting result (opens in a new tab)
To receive, consider and adopt: The standalone financial statements of the Company which includes the Audited Balance Sheet as at March 31, 2026, the Statement of Profit and Loss for the financial year ended as on that date and the Cash Flow Statement together with reports of the Board of Directors and the Statutory Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 46.46% · promoters 100.00% · institutions 0.00% · other public 43.88%
To receive, consider and adopt: The Consolidated financial statements of the Company which includes the Audited Balance Sheet as at March 31, 2026, the Statement of Profit and Loss for the financial year ended as on that date and the Cash Flow Statement together with reports of the Board of Directors and the Statutory Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 46.46% · promoters 100.00% · institutions 0.00% · other public 43.88%
- To appoint a director in place of Mr. Maggidi Venkatesh (DIN: 09414495), Non-Executive Director, who retires by rotation, and being eligible, has offered himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 46.46% · promoters 100.00% · institutions 0.00% · other public 43.88%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- No
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2026. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Preferential IssuesJan 2026 | 3.06 | To meet the long-term funding requirements of the Company for capital expenditure, working capital, general corporate purposes, etc. in order to support the future growth plan of the Company. | 3.06 | 3.06 | No |
| Preferential IssuesMay 2026 | 4.41 | To meet the long-term funding requirements of the Company for capital expenditure, working capital, general corporate purposes, etc. in order to support the future growth plan of the Company. | 4.41 | 4.41 | No |
| Preferential IssuesMay 2026 | 0.34 | To meet the long-term funding requirements of the Company for capital expenditure, working capital, general corporate purposes, etc. in order to support the future growth plan of the Company. | 0.34 | 0.09 | No |